Target- |
MechanismImmunomodulators |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date26 Aug 1991 |
Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismTBXA2R antagonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Zeria Usa, Inc.
0 Patents (Medical) associated with Zeria Usa, Inc.
100 Deals associated with Zeria Usa, Inc.
100 Translational Medicine associated with Zeria Usa, Inc.